Vocabria

Vocabria (cabotegravir) is an antiretroviral medication used for HIV treatment and prevention. This intramuscular injection supports long-acting therapy options for adults. Suitable for those seeking alternatives to daily oral regimens. Ideal for maintaining viral suppression with fewer dosing requirements.

Vocabria is used as part of combination therapy to treat HIV-1 infection in adults. It belongs to the integrase inhibitor class, working to reduce the amount of virus in the body. The medication is also approved for pre-exposure prophylaxis (PrEP) to help prevent HIV infection in high-risk adults. It is prescribed alongside other antiretrovirals for comprehensive viral control.

Cabotegravir may help maintain stable viral suppression when administered as directed. Users often report consistent energy levels and fewer gastrointestinal disturbances compared to some oral regimens. The intramuscular injection provides steady medication release over time, supporting adherence to therapy. Some individuals experience mild injection-site reactions, which are generally temporary.

Store cabotegravir injections at controlled room temperature away from moisture and heat. Keep the medication in its original packaging until ready for use. Discard any unused portion properly according to local regulations. Always follow healthcare provider instructions for handling and disposal to ensure safety.

Cabotegravir may interact with medications that affect liver enzymes, such as certain anticonvulsants or rifamycins. Combining it with strong CYP3A inducers can reduce its effectiveness. Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you use. Avoid alcohol if it worsens side effects or interacts with other therapies.